Not registered yet? Get a free account.

Sign Up
search icon cancel icon
ACUMEDS PHARMACEUTICALS LLP Location People Network Registered Details
We are excited to bring you Tofler 2.0! Being new, there might be a few hiccups. Please bear with us.

ACUMEDS PHARMACEUTICALS LLP

Active
Updated: 30 Jan 2021

Acumeds Pharmaceuticals Llp is a limited liability partnership incorporated on 22 January, 2021. Its registered office is at H NO 2 58 RAJAPUSHPA SUMMIT
6TH FLOOR NANAKRAMGUDA GACHIBOWLI
HYDERABAD

Industry

Health and Social Work

Locations

indian flag India (1)
State Type Address

location icon Locations on Map

Map placeholder

People

Designation Name DIN/PAN Tenure
Director Parupati Reddy Charan Raj 08048230 4 years
Director Sujith Reddy Parupati 07024313 4 years

Company Network

Companies connected through Directors

Name Status Paid up Capital Common Directors Address
RAJAPUSHPA HOLDINGS LIMITED
Active
5.5 Cr 1 Telangana
WATERMARKE ESTATES PRIVATE LIMITED
Active
40.4 L 1 Telangana
RAJAPUSHPA CORPORATE PRIVATE LIMITED
Active
3.0 L 1 Telangana
MARQUECHEM LIFE SCIENCES LLP
Active
1.0 L 1 Telangana
RAJAPUSHPA LANDMARK LLP
Active
1.0 L 1 Telangana
RAJAPUSHPA TRUSTNEST REALTY LLP
Active
1.0 L 1 Telangana
RAJAPUSHPA PROPERTIES PRIVATE LIMITED
Active
25.0 Cr 2 Telangana
RAJAPUSHPA INFRA PRIVATE LIMITED
Active
1.0 L 1 Telangana
STRATCHEM LABORATORIES LLP
Active
1.0 L 1 Telangana

Registered Details

CIN

AAV-5558

PAN

-

Incorporation

2021, 3.8 years

Website

-

Company Email

acumedspharmaceuticals@gmail.com

Telephone

7660005504

Contributed Capital

₹ 1.0 L

Designated Partners

2

Partners

0

Type

Limited Liability Partnership

Last MCA Filing
Reconfirm refresh img

Updated on : 30 Jan 2021
Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to... Read More